Skip to content

Clinical trials

Epstein-Barr Virus Infections trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epstein-Barr Virus Infections Country / region: Singapore Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20142
20151
20192
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting2
Completed2
Terminated2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene1
Cullinan Therapeutics Inc.1
NRG Oncology1
National University Hospital, Singapore1
SymBio Pharmaceuticals1
Tessa Therapeutics1
Viracta Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epstein-Barr Virus Infections7
Nasopharyngeal Carcinoma4
Nasopharyngeal Neoplasms4
Head and Neck Neoplasms2
Recurrence2
Immunoblastic Lymphadenopathy1
Leukemia-Lymphoma, Adult T-Cell1
Lymphoma1
Lymphoma, Large B-Cell, Diffuse1
Lymphoma, Large-Cell, Anaplastic1

Trials

Showing 26 to 7 of 7. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.